NK
Nirmal Kumar Ganguly
About Nirmal Kumar Ganguly
Data last updated:
Nirmal Kumar Ganguly has 20 years in corporate governance. Holds Director role. Currently with 4 companies, including Sapien Biosciences Private Limited and Pushpawati Singhania Hospital & Research Institute. Formerly with 5 companies, such as Ncd Predisease Forum and Artemis Medicare Services Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹196 Cr; the largest is Pushpawati Singhania Hospital & Research Institute at ₹192 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pushpawati Singhania Hospital & Research Institute U74899DL1995NPL070915 | Director | 30 Aug 2006 | 1995 | ₹192 Cr (FY 2025) | Active |
 Sapien Biosciences Private Limited U73100TG2012PTC080254 | Director | 29 Apr 2017 | 2012 | ₹3.62 Cr (FY 2025) | Active |
 Foundation For Disease Elimination And Control Of India U85190MH2016NPL286097 | Director | 01 Feb 2024 | 2016 | ₹13.4 Lakh (FY 2025) | Active |
 Indian Institute Of Translational Research Private Limited U72100DL2025PTC459812 | Director | 16 Dec 2025 | 2025 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ncd Predisease Forum U74999MH2016NPL285576 | Director | 06 Sep 2016 | 2016 | – | Active |
 Artemis Medicare Services Limited L85110DL2004PLC126414 | Director | 10 Feb 2014 | 2004 | ₹970 Cr (FY 2025) | Active |
 International Biotech Park Limited U74999MH2003PLC141236 | Director | 20 Sep 2012 | 2003 | ₹16.93 Cr (FY 2025) | Active |
 Gennova Biopharmaceuticals Limited U24231PN2001PLC016253 | Director | 30 May 2008 | 2001 | ₹376 Cr (FY 2023) | Active |
 Zenotech Laboratories Limited L27100TG1989PLC010122 | Director | 18 Jan 2011 | 1989 | ₹44.60 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirmal Kumar Ganguly
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirmal Kumar Ganguly
Nirmal Kumar Ganguly has 20 years in corporate governance. Holds Director role. Currently with 4 companies, including Sapien Biosciences Private Limited and Pushpawati Singhania Hospital & Research Institute. Formerly with 5 companies, such as Ncd Predisease Forum and Artemis Medicare Services Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹196 Cr; the largest is Pushpawati Singhania Hospital & Research Institute at ₹192 Cr (FY 2025).
Nirmal Kumar Ganguly is associated with 4 companies as Director, including Pushpawati Singhania Hospital & Research Institute (₹192 Cr), Sapien Biosciences Private Limited (₹3.62 Cr), Foundation For Disease Elimination And Control Of India (₹13.4 Lakh).
Nirmal Kumar Ganguly has expertise in General Business, Technology.
Nirmal Kumar Ganguly has 20 years in corporate governance.
By reported revenue, the largest current company of Nirmal Kumar Ganguly is Pushpawati Singhania Hospital & Research Institute, with revenue of ₹192 Cr (FY 2025).
The 3 current companies of Nirmal Kumar Ganguly that report revenue have a combined latest revenue of ₹196 Cr.
Nirmal Kumar Ganguly currently holds positions at 4 companies: Pushpawati Singhania Hospital & Research Institute (₹192 Cr), Sapien Biosciences Private Limited (₹3.62 Cr), Foundation For Disease Elimination And Control Of India (₹13.4 Lakh), Indian Institute Of Translational Research Private Limited.